Real-time enrollment status for this recurrent hodgkin lymphoma clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 9:14 PM UTC
| NCT Number | NCT04871607 |
| Recruiting Status | Recruiting |
| Condition | Recurrent Hodgkin Lymphoma |
| Phase | PHASE2 |
| Target Enrollment | 33 participants |
| Active Locations | 1 sites in the US |
| Sponsor | City of Hope Medical Center |
| Last Updated on CT.gov | December 4, 2025 (Dec 4, 2025) |
As of July 18, 2026: Clinical trial NCT04871607 is currently recruiting participants. This phase2 study for recurrent hodgkin lymphoma is actively seeking new participants at 1 location across the United States. The study is sponsored by City of Hope Medical Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04871607 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04871607 was last updated Dec 4, 2025 (December 4, 2025). HelloStudys verifies this status automatically.